search
Back to results

Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair

Primary Purpose

Laceration

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Intranasal ketamine
Sponsored by
Rhode Island Hospital
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Laceration focused on measuring Prospective, Randomized, Double blinded, Sedation, Ketamine, Intranasal

Eligibility Criteria

1 Year - 7 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Children between 1 to 7 years old
  • Simple facial laceration, defined as: linear; requiring two or more sutures; no greater than 5.0 centimeters; does not cross the lid margin of the eye; does not require a plastics/face surgery consult; occured within the last 24 hours.
  • Physician feels that intravenous sedation is required to perform the laceration repair

Exclusion Criteria:

  • Closed head injury, any alteration in level of consciousness, clinical suspicion of intracranial injury or increased intracranial pressure
  • Any conditions that qualify patient as American Society of Anesthesiologists' (ASA) III or IV
  • Known diagnoses of hyperthyroidism or porphyria
  • Glaucoma or penetrating eye injury
  • Hypertension
  • Any contraindication, including drug allergy, to study medications
  • Severe trauma with other injuries requiring operative intervention
  • Abnormal neurological exam in a previously normal child

Sites / Locations

  • Hasbro Children's Hospital

Outcomes

Primary Outcome Measures

Efficacy of sedation (OSBDR)
Time to onset of sedation (Ramsay 6-point Sedation Scale)

Secondary Outcome Measures

Duration of sedation
Primary caregiver satisfaction
Physician satisfaction
Ketamine bioavailability
Abnormalities in cardiopulmonary function
Administration of supplemental sedative medication
Prolonged sedation (i.e. > 1 hour)

Full Information

First Posted
March 21, 2007
Last Updated
July 21, 2010
Sponsor
Rhode Island Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT00451724
Brief Title
Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair
Official Title
Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair
Study Type
Interventional

2. Study Status

Record Verification Date
July 2010
Overall Recruitment Status
Completed
Study Start Date
May 2007 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
February 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Rhode Island Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to compare how well three different doses of ketamine, given as a spray into the nose, help to sedate children and help them tolerate repairs of cuts on their faces.
Detailed Description
Procedural sedation is frequently used to facilitate distressing and painful procedures in the pediatric emergency department. However, administering an intramuscular medication or placing an intravenous line to give intravenous medications can be as distressing as the procedure itself. Oral medications generally take longer to work and are subject to first-pass metabolism. Another alternative is to give the medication by the intranasal route, which only requires a spray into the nose. Ketamine is a good sedative drug with favorable qualities, and is often used intramuscularly or intravenously. It has been used intranasally as a pre-induction by anesthetics, sedation for CT scans, and brief dental procedures, but its use has not yet been demonstrated in the setting of the pediatric emergency department for procedural sedation. We will be comparing three different doses of ketamine, applied intranasally using a mucosal atomization device, and determining if there are any differences in efficacy of sedation, time to onset of sedation, duration of sedation, caregiver and physician satisfaction, and number of adverse events. We will also use this opportunity to determine ketamine bioavailability when given intranasally using the mucosal atomization device.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Laceration
Keywords
Prospective, Randomized, Double blinded, Sedation, Ketamine, Intranasal

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
45 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Intranasal ketamine
Primary Outcome Measure Information:
Title
Efficacy of sedation (OSBDR)
Time Frame
30 minutes
Title
Time to onset of sedation (Ramsay 6-point Sedation Scale)
Time Frame
30 minutes
Secondary Outcome Measure Information:
Title
Duration of sedation
Time Frame
Up to 1 hour
Title
Primary caregiver satisfaction
Time Frame
24 hours
Title
Physician satisfaction
Time Frame
Duration of procedure
Title
Ketamine bioavailability
Time Frame
1 hour
Title
Abnormalities in cardiopulmonary function
Time Frame
Until time of discharge
Title
Administration of supplemental sedative medication
Time Frame
During time required for procedure
Title
Prolonged sedation (i.e. > 1 hour)
Time Frame
Until time of discharge from emergency department

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
7 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Children between 1 to 7 years old Simple facial laceration, defined as: linear; requiring two or more sutures; no greater than 5.0 centimeters; does not cross the lid margin of the eye; does not require a plastics/face surgery consult; occured within the last 24 hours. Physician feels that intravenous sedation is required to perform the laceration repair Exclusion Criteria: Closed head injury, any alteration in level of consciousness, clinical suspicion of intracranial injury or increased intracranial pressure Any conditions that qualify patient as American Society of Anesthesiologists' (ASA) III or IV Known diagnoses of hyperthyroidism or porphyria Glaucoma or penetrating eye injury Hypertension Any contraindication, including drug allergy, to study medications Severe trauma with other injuries requiring operative intervention Abnormal neurological exam in a previously normal child
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James G Linakis, PhD, MD
Organizational Affiliation
Rhode Island Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hasbro Children's Hospital
City
Providence
State/Province
Rhode Island
ZIP/Postal Code
02903
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair

We'll reach out to this number within 24 hrs